LCM
Laurion Capital Management’s Dianthus Therapeutics DNTH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,536
| Closed | -$766K | – | 461 |
|
|
2024
Q1 | $766K | Sell |
25,536
-731
| -3% | -$21.9K | 0.01% | 226 |
|
|
2023
Q4 | $273K | Sell |
26,267
-10,126
| -28% | -$105K | ﹤0.01% | 210 |
|
|
2023
Q3 | $497K | Sell |
36,393
-545,907
| -94% | -$7.46M | ﹤0.01% | 165 |
|
|
2023
Q2 | $441K | Hold |
582,300
| – | – | ﹤0.01% | 199 |
|
|
2023
Q1 | $463K | Hold |
582,300
| – | – | ﹤0.01% | 169 |
|
|
2022
Q4 | $230K | Hold |
582,300
| – | – | ﹤0.01% | 178 |
|
|
2022
Q3 | $821K | Hold |
582,300
| – | – | ﹤0.01% | 169 |
|
|
2022
Q2 | $699K | Buy |
+582,300
| New | +$699K | 0.01% | 198 |
|
|
2020
Q3 | – | Sell |
-44,595
| Closed | -$334K | – | 677 |
|
|
2020
Q2 | $334K | Buy |
+44,595
| New | +$334K | ﹤0.01% | 486 |
|
|
2019
Q4 | – | Sell |
-96,217
| Closed | -$987K | – | 574 |
|
|
2019
Q3 | $987K | Sell |
96,217
-47,327
| -33% | -$485K | 0.01% | 282 |
|
|
2019
Q2 | $2.12M | Buy |
143,544
+132,497
| +1,199% | +$1.95M | 0.02% | 108 |
|
|
2019
Q1 | $182K | Sell |
11,047
-171,988
| -94% | -$2.83M | ﹤0.01% | 498 |
|
|
2018
Q4 | $1.04M | Sell |
183,035
-101,089
| -36% | -$576K | 0.02% | 230 |
|
|
2018
Q3 | $3.41M | Sell |
284,124
-65,876
| -19% | -$791K | 0.03% | 163 |
|
|
2018
Q2 | $4.73M | Buy |
+350,000
| New | +$4.73M | 0.04% | 169 |
|